Health
Larger panel finds more gene mutations, treatment targets for leukemia – Medical Xpress
A gene panel that looks for about 10 times the number of cancer-causing genes as panels currently used to diagnose and fine tune treatment for a variety of cancers…
A gene panel that looks for about 10 times the number of cancer-causing genes as panels currently used to diagnose and fine tune treatment for a variety of cancers is effective at identifying problematic genes in the most common leukemia, investigators report.
The 523-gene panel, developed by San Diego-based biotech company Illumina, which includes all genes known to potentially cause cancer, can be readily adopted for use in clinical laboratories to diagnose acute myeloid leukemia, or AML, the…
-
Noosa News20 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News21 hours agoYoung voices shape Sunshine Coast’s future
-
Business20 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News18 hours agoStar Entertainment signs $300m lifeline deal with US gaming giant Bally’s